|本期目录/Table of Contents|

[1]张 洁,万文辉,徐 军.铁缺乏与高龄慢性心衰患者脑钠肽水平的相关性分析[J].医学研究与战创伤救治(原医学研究生学报),2015,17(03):250-252.[doi:10.3969/j.issn.1672-271X.2015.03.008]
　ZHANG Jie,WAN Wen-hui,XU Jun..Relationship of iron deficiency and pro-B-type natriuretic peptide in elderly patients of chronic cardiac disfunction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(03):250-252.[doi:10.3969/j.issn.1672-271X.2015.03.008]
点击复制

铁缺乏与高龄慢性心衰患者脑钠肽水平的相关性分析()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第17卷
期数:
2015年03期
页码:
250-252
栏目:
出版日期:
2015-05-20

文章信息/Info

Title:
Relationship of iron deficiency and pro-B-type natriuretic peptide in elderly patients of chronic cardiac disfunction
作者:
张 洁; 万文辉; 徐 军
210002，江苏南京，南京军区南京总医院干部病区
Author(s):
ZHANG Jie;  WAN Wen-hui;  XU Jun.
Department of Senior Cadres， Nanjing General Hospital of Nanjing Military Command， PLA， Nanjing， Jiangsu 210002， China
关键词:
铁缺乏; 铁蛋白; 心功能不全; 脑钠肽前体
Keywords:
iron deficiency;  ferritin;  cardiac disfunction;  pro-BNP
分类号:
R541.6；R556
DOI:
10.3969/j.issn.1672-271X.2015.03.008
文献标志码:
A
摘要:
目的 心衰患者常存在铁缺乏现象，而并非所有心衰患者都合并贫血，铁缺乏可能是影响心功能的独立危险因素。通过检测高龄心衰患者脑钠肽前体水平及血清铁蛋白和(或)转铁蛋白饱和度水平，在校正影响心功能的其他相关因素后，探讨高龄心衰患者心功能与铁缺乏的相关性。方法 采集2011年1月-2013年12月因慢性心衰住院治疗的181例患者，根据血清铁蛋白水平分为铁缺乏组（105例）与铁正常组（76例）。单因素分析比较两组间脑钠肽前体水平、血红蛋白水平、肾小球率过滤、血脂、尿酸等指标，分析铁蛋白水平与脑钠肽前体的相关性。采用偏相关分析校正其他影响脑钠肽前体的因素后，分析铁蛋白水平与脑钠肽前体水平独立相关性。结果 铁缺乏组患者脑钠肽前体水平
[256.26±393.08）pmol/L]明显高于铁正常组[（152.28±189.90）pmol/L]，血红蛋白水平[（111.47±16.43）g/L]明显低于铁正常组[（118.87±19.51）g/L]，差异均有统计学意义（P<0.05）。其他指标如肾小球率过滤、尿酸、血脂等，两组组间差异无统计学意义。偏相关分析校正血红蛋白等对脑钠肽的影响，示血清铁蛋白水平和脑钠肽前体水平独立负相关（r=-0.160，P=0.030）。结论 高龄心功能不全患者心衰的严重程度（脑钠肽前体水平）与铁缺乏的程度（血清铁蛋白水平）呈独立负相关。
Abstract:
Objective Studies have confirmed that the phenomenon of iron deficiency is common in patients with heart failure and not all patients combined with anemia. Iron deficiency may be the independent risk factor of heart dysfunction. Based on the detection of pro-BNP levels with elderly heart failure patients and serum ferritin and/or transferrin saturation levels， after adjustment for other related influencing factors of cardiac function， to explore the correlation of cardiac function in elderly patients with iron deficiency. Methods 181 patients with chronic heart failure， hospitalized from January 2011 to December 2013， were collected according to the serum ferritin level. These patients were divided into iron deficiency group （105 cases） and normal group （76 cases）. Single factor analysis and comparison of two groups of pro-BNP， hemoglobin levels， rate of glomerular filtration， blood lipid， uric acid were carried out. We confirmed that ferritin level is correlated to pro-BNP. At the same time， the partial correlation analysis after correction for other factors， which affect the pro-BNP， obtain that iron protein levels associated with pro-BNP levels independently. Results pro-BNP (256.26±393.08）pmol/L of iron deficiency group was significantly higher than that in patients in iron normal group (152.28±189.90）pmol/L. The hemoglobin levels (111.47±16.43）g/L was lower than that in iron normal group patients (118.87±19.51）g/L. The difference was statistically significant (P<0.05). There was no statistically significant difference between the two groups in other indicators such as the rate of glomerular filtration， uric acid， blood lipids and so on. Using partial correlation analysis and corrected the hemoglobin which affect pro-BNP: serum ferritin level independently negative correlated with the level of pro-BNP (r=0.160， P=0.030). Conclusion The severity (pro-BNP) of heart failure patients in elderly is independent negatively related to the degree of iron deficiency (serum ferritin level).

参考文献/References:

[1]Parikh A，Natarajan S，Lipsitz SR，et al .Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III：prevalence and associations with anemia and inflammation[J].Circ Heart Fail，2011，4(5):599-606.
[2]Rhodes CJ，Wharton J，Howard L，et al.Iron deficiency in pulmonary arterial hypertension：a potential therapeutic target[J].Eur Respir J，2011，38(6)：1453-1460.
[3]Ankit P，Sundar N，Stuart RL，et al.Iron deficiency in community-dwelling US adults with self-reported heart failure in NHANES III：prevalence and associations with anemia and inflammation[J].Circulation，2011，4(5)：599-606.
[4]Okonko DO，Mandal AK，Missouris CG，et al.Disordered iron homeostasis in chronic heart failure：prevalence，predictors，and relation to anemia，exercise capacity，and survival[J].J Am Coll Cardiol，2011，58(12)：1241-1251.
[5]Jankowska EA，Rozentryt P，Witkowska A，et al.Iron deficiency：an ominous sign in patients with systolic chronic heart failure[J].Eur Heart，2010，31(3)：1872-1880.
[6]Klip IT，Comin-Colet J，Voors AA，et al.Iron deficiency in chronic heart failure：an international pooled analysis[J].Am Heart J，2013，165(3)：575-582.
[7]Anker SD，Comin Colet J，Filippatos G，et al.Ferric carboxymaltose in patients with heart failure and iron deficiency[J].Eur Heart J，2009，361(12)：2436-2448.
[8]Jankowska EA，Rozentryt P，Witkowska A，et al.Iron deficiency：an ominous sign in patients with systolic chronic heart failure[J].Eur Heart J，2010，31(15)：1872-1880.
[9]McMurray JJ，Adamopoulos S，Anker SD，et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur Heart Fail，2012，14(1)：803-819.
[10]Chen JB，Chiang SS，Chen HC，et al.Efficacy and safety of SBR759，a novel calcium-free，iron(III)-based phosphate binder，in Asian patients undergoing hemodialysis：a 12-week，randomized，open-label，dose-titration study versus sevelamer hydrochloride[J].Nephrology (Carlton)，2011，16(8)：743-750.
[11]Fishbane S，Pollack S，Feldman HI，et al.Iron indices in chronic kidney disease in the National Health and Nutritional Exa rome content of rat heart mitochondria[J].Circulation Res，1976，39(5)：134-137.
[12]Anker SD，Colet JC，Filippatos G，et al.Rationale and design of Ferinject assessment in patients with iron deficiency and chronic heart failure(FAIR-HF) study：a randomized，placebo-controlled study of intravenous iron supplementation in patients with and without anaemia[J].Eur J Heart Fail，2009，11(1)：1084-1091.
[13]Cohen-Solal A，Damy T，Hanon O，et al.High prevalence of iron deficiency in patients admitted for acute decompensated heart failure：a French study(Cardiofer)[J].Am Heart J，2014，63(12)：779-785.

相似文献/References:

[1]尹小芳,孟月,傅元冬,等.血清铁蛋白与急性呼吸窘迫综合征的相关性[J].医学研究与战创伤救治(原医学研究生学报),2022,24(3):242.[doi:10.3969/j.issn.1672-271X.2022.03.004]
　YIN Xiao-fang,MENG Yue,FU Yuan-dong,et al.Correlation between serum ferritin and acute respiratory distress syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(03):242.[doi:10.3969/j.issn.1672-271X.2022.03.004]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2015-05-20